ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0449 • ACR Convergence 2024

    Evaluating Premenstrual Dysphoric Disorder in Women with Rheumatoid Arthritis and Healthy Female Subjects

    Ana Cecilia Bardan-Inchaustegui1, Iris Jazmín Colunga Pedraza2, Rosa Icela Arvizu-Rivera2, Gisela Garcia-Arellano3, Griselda Serna-Peña4, Maria F. Elizondo-Benitez5, Aleydis Gonzalez Melendez2, Fernanda Massiel Garcia6 and Dionicio Galarza-Delgado7, 1Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Hospital Universitario \"Dr. José Eleuterio González\", Monterrey, Nuevo León, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 6Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome, is classified as a psychiatric disorder characterized by moderate to severe physical, affective, or…
  • Abstract Number: 0418 • ACR Convergence 2024

    Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice

    Megan Clowse1, Puneet Bajaj2, Bonnie Bermas2, Julie Chiesa3, Kathryn Dao4, Pamela Freeman5, Bansari Gujar6, Brittany Hill7, Kelley Jones8, Richard Jones9, Ann Marslett10, Brooke Mills11, James Roberts2, Amanda Snyderman8 and Leah Zulig12, 1Duke University, Chapel Hill, NC, 2UT Southwestern Medical Center, Dallas, TX, 3InfoDirectors, Durham, NC, 4Rheum101, Rockville, MD, 5Rheumatology Associates of Central Florida, Orlando, FL, 6Rheumatology Associates of Baltimore, Towson, MD, 7Clinic for Rheumatic Disease, Tuscaloosa, AL, 8Duke University School of Medicine, Durham, 9Clinic for Rheumatic Diseases, Northport, AL, 10Rheumatology Associates of Baltimore, Baltimore, MD, 11UT Southwestern Medical Center, Fort Worth, TX, 12Duke University School of Medicine, Durham, NC

    Background/Purpose: Prior studies of RISE Registry found 9-11% of women of reproductive age with contraception documentation.  We sought to identify and assess methods to increase contraception documentation…
  • Abstract Number: 0464 • ACR Convergence 2024

    Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population

    Amir Razmjou1, Rong Guo2, David Elashoff3, Kevin Deane4, Jill Norris5, Marie Feser6, Jennifer Wang1, Ani Shahbazian2 and christina Charles-Schoeman7, 1UCLA, Los Angeles, CA, 2UCLA, Los Angeles, 3UCLA Department of Medicine Statistics Core, Los Angeles, 4University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 5Colorado School of Public Health, Denver, CO, 6Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 7UCLA Medical Center, Santa Monica, CA

    Background/Purpose: Rheumatoid arthritis (RA) has a well described pre-clinical state, with a continuum of genetic and environmental risk factors leading to the development of systemic…
  • Abstract Number: 0472 • ACR Convergence 2024

    Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis

    Bas Dijkshoorn1, Sreen Mohamed2, Romy Hansildaar2, Henk Everaars3, Geoffrey Mooij3, Luuk Hopman3, Paul Knaapen3, Lourens Robbers3 and Michael Nurmohamed4, 1Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and Immunology center location Reade, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands, Amsterdam, Netherlands, 4Amsterdam University Medical Centers, Amsterdam, Netherlands

    Background/Purpose: Heart failure (HF) is an important, underdiagnosed comorbidity, with increased morbidity and mortality rates in rheumatoid arthritis (RA) patients. The risk of developing HF…
  • Abstract Number: 0388 • ACR Convergence 2024

    The Association Between Body Composition and Disease and Treatment Outcomes in Patients with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry

    Samantha Morin1, KAREN BEATTIE2, Roxana Bolaria3, Tania Cellucci4, Gaelle Chedeville5, Amieleena Chhabra6, Paul Dancey7, Tommy Gerschman8, Liane Heale9, Julie Herrington2, Adam Huber10, Mehul Jariwala11, Jean-Philippe Proulx-Gauthier12, Dax Rumsey13, Heinrike Schmeling14, Jaime Guzman15 and Michelle Batthish4, and CAPRI Registry Investigators, 1McMaster University, Hamilton, Canada, 2McMaster University, Hamilton, ON, Canada, 3Victoria Arthritis Center, Victoria, BC, Canada, 4McMaster Children's Hospital, Hamilton, ON, Canada, 5The Montreal Children's Hospital, Montreal, QC, Canada, 6University of British Columbia, Penticton, BC, Canada, 7Memorial University, St. John's, Canada, 8University of British Columbia - Vancouver, North Vancouver, BC, Canada, 9McMaster University, Oakville, ON, Canada, 10IWK Health Centre, Halifax, NS, Canada, 11Jim Pattison Children's Hospital, Saskatoon, Canada, 12CHU de Quebec - Universite Laval, Quebec, QC, Canada, 13University of Alberta, Edmonton, AB, Canada, 14University of Calgary, Calgary, AB, Canada, 15University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: Recent evidence has linked abnormal body weight, underweight or obesity, with poor disease outcomes in adults with inflammatory arthritis. Yet, little is known about…
  • Abstract Number: 0389 • ACR Convergence 2024

    Histopathological Features of Liver Tissue Biopsies in SJIA Patients with and Without Clinical Macrophage Activation Syndrome

    Esraa Eloseily1, Lara Berklite2, Jennifer Picarsic1, grant schulert1, Rachel Sheridan1 and Alexei Grom1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnti, OH

    Background/Purpose: Systemic Juvenile Idiopathic Arthritis (SJIA) can present with or without Macrophage Activation Syndrome (MAS), a severe, potentially life-threatening complication. Liver tissue injury is commonly…
  • Abstract Number: 0429 • ACR Convergence 2024

    Exploring the Impact of Autoimmune Rheumatic Diseases on Human Milk Macronutrient Composition

    Rashmi Dhital1, Kerri Bertrand2, Essi Heinonen3 and Christina Chambers4, 1UC San Diego, Brentwood, TN, 2UC San Diego, San Diego, CA, 3UC San Diego, La Jolla, CA; Karolinska Institutet, Stockholm, Sweden, San Diego, CA, 4University of California, San Diego, La Jolla, CA

    Background/Purpose: Systemic inflammation in autoimmune rheumatic diseases (ARDs) may alter human milk composition, akin to changes observed in other inflammatory states, indirectly impacting infant health,…
  • Abstract Number: 0463 • ACR Convergence 2024

    Evaluation of Inflammatory Indices as Predictive Biomarkers of Carotid Plaque in Patients with Rheumatoid Arthritis

    Jose Antonio Davila Jimenez1, Dionicio Galarza-Delgado2, Iris Jazmín Colunga Pedraza3, jose Ramon Azpiri-Lopez4, Rosa Icela Arvizu-Rivera3, Jesus Cardenas-de la Garza5, Aleydis Gonzalez Melendez3, Andrea Guajardo Aldaco3, Maria F. Elizondo-Benitez6, Rebeca L. Polina-Lugo3 and Diego Salcedo-Almanza7, 1Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 2UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 5Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 7Division of Radiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico

    Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased cardiovascular (CV) risk compared to the general population. All stages of the atherogenic process appear to…
  • Abstract Number: 0445 • ACR Convergence 2024

    Evaluating Clinical Reasoning in Randomized Surveys of Lupus Nephritis and Preeclampsia Pregnancy Case Workups: A Clinical Conundrum

    Liya Stolyar1, Sadaf Sediqi2, Richard Lafayette3, Maurice Druzin4, Saadiya Hawa5, Amanda Moyer6, Yashaar Chaichian2 and Julia Simard2, 1Palo Alto VA Medical Center/Stanford, Stanford, CA, 2Stanford School of Medicine, Stanford, CA, 3Stanford, Stanford, CA, 4Stanford University School of Medicine, Stanford, CA, 5Weiss Memorial Hospital, Chicago, IL, 6Stanford University, San Bruno, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) pregnancy is associated with a heightened risk of adverse pregnancy outcomes, including preeclampsia. Distinguishing preeclampsia from lupus nephritis (LN) presents…
  • Abstract Number: 0390 • ACR Convergence 2024

    Treatment Effectiveness Following Switching from Initial TNF Inhibitor in Juvenile Idiopathic Arthritis

    Mei-Sing Ong1, Sarah Ringold2, Melissa Mannion3, Marc Natter4 and Yukiko Kimura5, 1Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, MA, 2Washington University, Seattle, 3University of Alabama at Birmingham, Birmingham, AL, 4Boston Children's Hospital, Boston, MA, 5Hackensack Meridian School of Medicine, New York, NY

    Background/Purpose: Although the increasing availability of biologic therapies has significantly improved outcomes for patients with JIA, a substantial proportion of patients require switching from the…
  • Abstract Number: 0387 • ACR Convergence 2024

    Absolute Agreement and Inter-rater Reliability of a Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) Amongst Radiologists

    Farzana Nuruzzaman1, T. Shawn Sato2, Jennifer Stimec3, Ramesh S. Iyer4, Andrew Carbert5, Joel Paschke5, Lauren Potts6, Xiaoyue Zhang7, Walter Maksymowych8, Polly Ferguson9 and Yongdong (Dan) Zhao10, and CARRA CRMO Workgroup, 1Stony Brook Children's Hospital, Stony Brook, NY, 2University of Iowa, Iowa City, 3Hospital for Sick Children, Toronto, ON, Canada, 4Seattle Children's Hospital, Seattle, WA, 5CARE Arthritis, Edmonton, AB, Canada, 6Artist, Long Beach, CA, 7Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 8University of Alberta, Edmonton, AB, Canada, 9University of Iowa Carver College of Medicine, Iowa City, IA, 10University of Washington, Redmond, WA

    Background/Purpose: The web-based ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) portal was developed to assess specific features of bone and soft tissue inflammation in…
  • Abstract Number: 0477 • ACR Convergence 2024

    The Global Prevalence of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis

    Hari Prasanna1, Charles Inderjeeth2, Johannes Nossent3 and KHALID ALMUTAIRI4, 1University of Western Australia, Perth, Western Australia, Australia, 2SCGH and OPH Group & University of Western Australia, Perth, Western Australia, Australia, 3University of Western Australia, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia, 4The University of Western Australia, Perth, Western Australia, Australia

    Background/Purpose: Interstitial lung disease (ILD) is a common manifestation of rheumatoid arthritis (RA) that severely impacts the health outcomes of RA patients. Despite this, the…
  • Abstract Number: 0475 • ACR Convergence 2024

    Rheumatoid Arthritis – Progressive Interstitial Lung Disease with Abatacept: Data from a Large National Multicenter Cohort

    Ana Serrano-Combarro1, Belén Atienza-Mateo2, Libe Ibarrola Paino3, Ivette Casafont-Sole4, Jesús Loarce5, Juan María Blanco Madrigal6, Santos Castañeda7, Rafaela Ortega-Castro8, Natalia Mena Vázquez9, Nuria Vegas Revenga10, Lucia Cristina Dominguez Casas11, Cilia Peralta Ginés12, Carolina Diez Morrondo13, Lorena Pérez Albadalejo14, Rubén López Sánchez15, MARIA GUADALUPE MANZANO CANABAL16, Anahy Maria Brandy-Garcia17, Patricia Lopez Viejo18, Gema Bonilla19, Olga Maíz Alonso20, Carmen Carrasco-Cubero21, Marta Garijo Bufort22, Mireia Moreno Martinez-Losa23, Ana Urruticoechea-Arana24, Sergi Ordoñez25, Carmen González Montagut26, Andrea García-Valle27, Juan Ramón De Dios28, Patricia Carreira29, Tomás Vázquez Rodríguez30, Delia Fernández-Lozano31, Ignacio Brana Abascal32, Rafael Benito Melero-Gonzalez33, Emilio Giner34, Virginia Ruiz Esquide35, Clara Ventin Rodriguez36, Marina Rodriguez37, Pablo Andújar-Brazal38, Julia Fernandez Melon39, Lilian M. López-Núñez40, JOSE RAMON LAMUA RIAZUELO41, Carlos Fernández Díaz42, Javier Loricera43 and Ricardo Blanco-Alonso44, 1Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 2Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 3Rheumatology Division, Bisadoa Hospital, Bidasoa, Spain, 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 5Ramón y Cajal University Hospital, Madrid, Madrid, Spain, 6Basurto University Hospital, Bilbao, Spain, 7Hospital Universitario de la Princesa, Madrid, Spain, 8Hospital Reina Sofía, Cordoba, Andalucia, Spain, 9IBIMA, Málaga, Andalucia, Spain, 10Hospital Galdakao- Usansolo, Galdakao, Spain, 11Hospital Universtario San Agustin, Oviedo, Spain, 12Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 13Hospital de Leon, León, Spain, 14Hospital Universitario de Jaén, Jaén, Spain, 15Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain, 16CAZA, Salamanca, Spain, 17Hospital Germans Trias i Pujol, Badalona, Spain, 18Hospital Severo Ochoa, Madrid, Madrid, Spain, 19H. Universitario La Paz, Madrid, Spain, 203Hospital Universitario de Donosti, San Sebastian, Spain, San Sebastian, Pais Vasco, Spain, 21Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain, 22Hospital de Sagunto, Valencia, Spain, 23Parc Tauli Hospital Universitari, I3PT(UAB), Barcelona, Spain, 24Hospital Son Espases, Palma de Mallorca, Islas Baleares, Spain, 25Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain, 26Hospital Universitario de Valladolid, Valladolid, Spain, 27Hospital General Río Carrión, Palencia, Spain, 28Osakidetza, Vitoria, Spain, 29Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain, 30Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain, 31Hospital Clínico Universitario de Valencia, Valencia, Spain, 32Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain, 33CHU Ourense, O Carballino, Spain, 34Hospital Royo Villanova, Teruel, Spain, 35Hospital Clinic Barcelona, Barcelona, Spain, 36Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain, 37Hospital Clínico Universitario de Santiago, La Coruna, Spain, 38Hospital Universitario Doctor Peset, Valencia, Spain, 39Hospital Son Espases, Palma, Spain, 40Hospital Universitari Son Llàtzer, Palma, Spain, 41Hospital Universitario del Henares, Madrid, Spain, 42Hospital Universitario Santa Lucía, Cartagena, Spain, 43Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 44Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Interstitial lung disease (ILD) is a severe extra-articular manifestation of rheumatoid arthritis (RA). Abatacept (ABA) has demonstrated effectiveness in the treatment of RA-ILD, regardless…
  • Abstract Number: 0399 • ACR Convergence 2024

    Eosinophilia and Exposure to IL-1 and IL-6 Blocking Biologic Medications in a Systemic Juvenile Idiopathic Arthritis Patient Cohort

    Rachel Dickey1, Doel Dhar2, Srushti Gangireddy3, Henry H. Ong3, Wei-Qi Wei3 and Anna Patrick3, 1Lipscomb University College of Pharmacy, Athens, TN, 2Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, TN, 3Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is a severe disease with symptoms of fevers, rash, and arthritis. High levels of the inflammatory cytokines interlukin-1 (IL-1)…
  • Abstract Number: 0407 • ACR Convergence 2024

    Prevalence of Autoimmune Diseases in 8244 Family Members of Children with Juvenile Idiopathic Arthritis: A Study from India

    Lekshmi Minikumari Rahulan1, Able Lawrence2 and Amita Aggarwal3, 1Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 2SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

    Background/Purpose: Familial aggregation of autoimmune disease as well as co-occurrence of multiple autoimmune diseases in one individual is known and it suggests a shared genetic…
  • « Previous Page
  • 1
  • …
  • 336
  • 337
  • 338
  • 339
  • 340
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology